Study to Determine Adequate Margins in Radiotherapy Planning for Esophageal Carcinoma by Detailing Patterns of Recurrence After Definitive Chemoradiotherapy-Reference-Cited by-同舟云学术

Study to Determine Adequate Margins in Radiotherapy Planning for Esophageal Carcinoma by Detailing Patterns of Recurrence After Definitive Chemoradiotherapy

Published:2009-03 Issue:3 Volume:73 Page:818-823
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Button Michael R.,Morgan Carys A.,Croydon Elizabeth S.,Roberts S. Ashley,Crosby Thomas D.L.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference31 articles.

1. Definitive chemoradiation in patients with inoperable oesophageal carcinoma;Crosby;Br J Cancer,2004

2. Randomized phase III trial in locally advanced esophageal cancer: Radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102) [Abstract];Bedenne;Proc Am Soc Clin Oncol,2002

3. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus;Stahl;J Clin Oncol,2005

4. Chemotherapy of locally advanced esophageal cancer: Long term follow-up of a prospective randomized trial (RTOG 85-01);Cooper;JAMA,1999

5. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy;Minsky;J Clin Oncol,2002

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma;Frontiers in Oncology;2024-01-26

2. Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial;eClinicalMedicine;2023-07

3. Low body mass index is associated with poor treatment outcome following radiotherapy in esophageal squamous cell carcinoma;Radiation Oncology Journal;2023-03-31

4. Radiation Dose-Effect Relation in Patients with Esophageal Squamous Cell Carcinoma: A National Cancer Center Data and Literature-Based Analysis;Journal of Oncology;2022-10-22

5. Dose escalation based on 18F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12);Radiation Oncology;2022-07-29